What If Cancer Medicine Was Made Just For You?
In this monologue, the speaker critiques the conventional oncology paradigm that relies on one-size-fits-all double‑blind placebo trials and limited diagnostic data (typically a few biopsies, tumor markers, and imaging). They note that while integrative medicine strives to support healing by providing energy and fuel, it often lacks the precision needed for individual patients. The core of the talk introduces the "n‑of‑1" concept: a treatment strategy built entirely around the individual patient, using their unique molecular profile. The speaker describes how molecular tumor boards convene regularly to analyze thousands of data points per patient—far exceeding the dozen or so data points considered in standard practice—allowing truly personalized therapeutic decisions for each cancer type, stage, and patient.
